Clinical Trial Detail

NCT ID NCT03821233
Title A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Zymeworks Inc.
Indications

breast cancer

gastroesophageal adenocarcinoma

Advanced Solid Tumor

Therapies

ZW49

Age Groups: senior adult

Additional content available in CKB BOOST